122 related articles for article (PubMed ID: 38930137)
1. Clinical Characteristics of Cutaneous Pain in Psoriasis.
Kotewicz M; Krajewski PK; Jaworek AK; Szepietowski JC
J Clin Med; 2024 Jun; 13(12):. PubMed ID: 38930137
[No Abstract] [Full Text] [Related]
2. Psychometric properties of the itch numeric rating scale, skin pain numeric rating scale, and atopic dermatitis sleep scale in adult patients with moderate-to-severe atopic dermatitis.
Silverberg JI; DeLozier A; Sun L; Thyssen JP; Kim B; Yosipovitch G; Nunes FP; Gugiu PC; Doll HA; Eichenfield LF
Health Qual Life Outcomes; 2021 Oct; 19(1):247. PubMed ID: 34688290
[TBL] [Abstract][Full Text] [Related]
3. Validation of Psychometric Properties of the Itch Numeric Rating Scale for Pruritus Associated With Prurigo Nodularis: A Secondary Analysis of a Randomized Clinical Trial.
Kimel M; Zeidler C; Kwon P; Revicki D; Ständer S
JAMA Dermatol; 2020 Dec; 156(12):1354-1358. PubMed ID: 32936233
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of brodalumab in improving itching and skin pain in Japanese patients with psoriasis: The ProLOGUE study.
Honma M; Kanai Y; Murotani K; Ito K; Ohata C; Yamazaki F; Saeki H; Seishima M; Mizutani Y; Kitabayashi H; Imafuku S
J Dermatol; 2023 Apr; 50(4):453-461. PubMed ID: 36540010
[TBL] [Abstract][Full Text] [Related]
5. Effect of Ixekizumab on Patient Reported Outcomes and Quality of Life in Patients With Moderate-to-Severe Plaque Psoriasis: 5-Year Results from the UNCOVER-1 and -2 Studies.
Gooderham MJ; Elewski B; Augustin M; Iversen L; Torii H; Burge R; See K; Gallo G; Eastman WJ; McKean-Matthews M; Foley P
J Drugs Dermatol; 2021 Apr; 20(4):394-401. PubMed ID: 33852247
[TBL] [Abstract][Full Text] [Related]
6. Effect of Roflumilast Cream (ARQ-151) on Itch and Itch-Related Sleep Loss in Adults with Chronic Plaque Psoriasis: Patient-Reported Itch Outcomes of a Phase 2b Trial.
Stein Gold L; Alonso-Llamazares J; Draelos ZD; Gooderham MJ; Kempers SE; Kircik LH; Lebwohl MG; Papp KA; Pariser DM; Toth DP; Yosipovitch G; Higham RC; Feng A; Berk DR
Am J Clin Dermatol; 2023 Mar; 24(2):305-313. PubMed ID: 36370336
[TBL] [Abstract][Full Text] [Related]
7. Qualitative analysis and reproducibility assessment of the Scalp Itch Numeric Rating Scale among patients with moderate to severe plaque psoriasis of the scalp.
Wang Y; Coyne K; Sofen H; Santanello N; Currie B; Zhang Z; Nograles K
J Dermatolog Treat; 2019 Dec; 30(8):775-783. PubMed ID: 30747550
[No Abstract] [Full Text] [Related]
8. Psychometric properties of the Itch Numeric Rating Scale in patients with moderate-to-severe plaque psoriasis.
Kimball AB; Naegeli AN; Edson-Heredia E; Lin CY; Gaich C; Nikaï E; Wyrwich K; Yosipovitch G
Br J Dermatol; 2016 Jul; 175(1):157-62. PubMed ID: 26852717
[TBL] [Abstract][Full Text] [Related]
9. Impact of ixekizumab on psoriasis itch severity and other psoriasis symptoms: Results from 3 phase III psoriasis clinical trials.
Kimball AB; Luger T; Gottlieb A; Puig L; Kaufmann R; Nikaï E; Zhu B; Edson-Heredia E; Carlier H; Lin CY; Goldblum O; Yosipovitch G
J Am Acad Dermatol; 2016 Dec; 75(6):1156-1161. PubMed ID: 27692498
[TBL] [Abstract][Full Text] [Related]
10. Utility of the Dermatology Life Quality Index at initiation or switching of biologics in real-life Japanese patients with plaque psoriasis: Results from the ProLOGUE study.
Imafuku S; Kanai Y; Murotani K; Nomura T; Ito K; Ohata C; Yamazaki F; Miyagi T; Takahashi H; Okubo Y; Saeki H; Honma M; Tada Y; Mabuchi T; Higashiyama M; Kobayashi S; Hashimoto Y; Seishima M; Kakuma T
J Dermatol Sci; 2021 Mar; 101(3):185-193. PubMed ID: 33495058
[TBL] [Abstract][Full Text] [Related]
11. Exploring content and psychometric validity of newly developed assessment tools for itch and skin pain in atopic dermatitis.
Newton L; DeLozier AM; Griffiths PC; Hill JN; Hudgens S; Symonds T; Gable JC; Paik J; Wyrwich KW; Eichenfield LF; Abetz-Webb L; Silverberg JI
J Patient Rep Outcomes; 2019 Jul; 3(1):42. PubMed ID: 31312940
[TBL] [Abstract][Full Text] [Related]
12. Measuring pain in systemic sclerosis: comparison of the short-form McGill Pain Questionnaire versus a single-item measure of pain.
El-Baalbaki G; Lober J; Hudson M; Baron M; Thombs BD;
J Rheumatol; 2011 Dec; 38(12):2581-7. PubMed ID: 21965643
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of Avène Hydrotherapy on Chronic Pruritus in Patients with Plaque Psoriasis.
Thouvenin MD; Bacquey A; Babin M; Lestienne F; Lauze C; Gravier E; Placintescu D; Ortiz-Brugués A; Ständer S
Dermatol Ther (Heidelb); 2023 Dec; 13(12):3137-3151. PubMed ID: 37837493
[TBL] [Abstract][Full Text] [Related]
14. Impact of Ixekizumab Treatment on Itch and Psoriasis Area and Severity Index in Patients with Moderate-to-Severe Plaque Psoriasis: An Integrated Analysis of Two Phase III Randomized Studies.
Yosipovitch G; Reich A; Steinhoff M; Beselin A; Kent T; Dossenbach M; Berggren L; Henneges C; Luger T
Dermatol Ther (Heidelb); 2018 Dec; 8(4):621-637. PubMed ID: 30465321
[TBL] [Abstract][Full Text] [Related]
15. Psychometric validation and meaningful change thresholds of the Worst Itching Intensity Numerical Rating Scale for assessing itch in patients with chronic kidney disease-associated pruritus.
Vernon MK; Swett LL; Speck RM; Munera C; Spencer RH; Wen W; Menzaghi F
J Patient Rep Outcomes; 2021 Dec; 5(1):134. PubMed ID: 34952964
[TBL] [Abstract][Full Text] [Related]
16. Work productivity in real-life employed patients with plaque psoriasis: Results from the ProLOGUE study.
Saeki H; Kanai Y; Murotani K; Ito K; Miyagi T; Takahashi H; Tada Y; Higashiyama M; Hashimoto Y; Kitabayashi H; Imafuku S
J Dermatol; 2022 Oct; 49(10):970-978. PubMed ID: 35856276
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics of itch in cutaneous lupus erythematosus: A prospective, multicenter, multinational, cross-sectional study.
Samotij D; Szczęch J; Antiga E; Bonciani D; Caproni M; Chasset F; Dańczak-Pazdrowska A; Furukawa F; Hasegawa M; Hashizume H; Ikeda T; Islam A; Kim HJ; Lesiak A; Misery L; Mowla MR; Polańska A; Szepietowski JC; Tsuruta D; Verdelli A; Werth VP; Reich A
Lupus; 2021 Aug; 30(9):1385-1393. PubMed ID: 34000879
[TBL] [Abstract][Full Text] [Related]
18. Measurement properties of the patient global assessment numerical rating scale in moderate-to-severe psoriasis.
Yu N; Peng C; Zhou J; Gu J; Xu J; Li X; Bi X; Deng H; Li X; Ding Y; Shi Y
Br J Dermatol; 2023 Sep; 189(4):437-446. PubMed ID: 37310289
[TBL] [Abstract][Full Text] [Related]
19. Brodalumab and ixekizumab, anti-interleukin-17-receptor antibodies for psoriasis: a critical appraisal.
Spuls PI; Hooft L
Br J Dermatol; 2012 Oct; 167(4):710-3; discussion 714-5. PubMed ID: 23013312
[TBL] [Abstract][Full Text] [Related]
20. Measurement properties of the Patient-Reported Outcomes Information System (PROMIS
Silverberg JI; Lai JS; Patel KR; Singam V; Vakharia PP; Chopra R; Sacotte R; Kantor R; Hsu DY; Cella D
Br J Dermatol; 2020 Nov; 183(5):891-898. PubMed ID: 32107772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
